Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Sachiko YokooKen-ichi Inui

Abstract

The effect of oxaliplatin against colorectal cancer is superior to that of cisplatin, but the molecular mechanism(s) involved is not clear. We found previously that oxaliplatin, but not cisplatin, was transported by human (h) and rat organic cation transporter 3 (OCT3)/SLC22A3. In the present study, we examined whether hOCT3 was significantly involved in the oxaliplatin-induced cytotoxicity and accumulation of platinum in colorectal cancer. The level of hOCT3 mRNA in the colon was 9.7-fold higher in cancerous than in normal tissues in six Japanese patients (P = 0.0247). In human colorectal cancer-derived cell lines, the mRNA of hOCT3 was highly expressed compared with that of other organic cation transporters. The release of lactate dehydrogenase (LDH) and accumulation of platinum with oxaliplatin treatment were increased in SW480 cells transfected with hOCT3 cDNA compared with empty vector-transfected cells. T84 and SW837 cells, with high levels of hOCT3, released more LDH and accumulated more platinum after oxaliplatin treatment than low hOCT3-expressing cells such as SW480, HCT116, HT29, and Lovo. However, the amount of platinum accumulated after cisplatin treatment did not differ among these six cell lines. The levels of hO...Continue Reading

References

Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J LoehrerS Meyer
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A de GramontA Bonetti
Sep 6, 2000·Kidney International·K I InuiH Saito
Mar 26, 2002·Journal of the American Society of Nephrology : JASN·Hideyuki MotohashiKen-Ichi Inui
Jun 6, 2003·Medicinal Research Reviews·Yee-Ping HoKenneth K W To
Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard M GoldbergSteven R Alberts
Jun 4, 2004·The New England Journal of Medicine·Thierry AndréUNKNOWN Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC)
Jun 24, 2004·Pharmaceutical Research·Yumiko UrakamiKen-ichi Inui
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Nov 30, 2005·The American Journal of Pathology·Giuliano CiarimboliEberhard Schlatter
Apr 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew X ZhuKeith Stuart
Sep 5, 2006·Cancer Research·Shuzhong ZhangKathleen M Giacomini
Jul 13, 2007·Nature Reviews. Cancer·Lloyd Kelland
Nov 22, 2007·Cancer Chemotherapy and Pharmacology·Noriaki KitadaTeruyoshi Yokoyama
Feb 12, 2008·Biochemical Pharmacology·Tomohiro Terada, Ken-ichi Inui

❮ Previous
Next ❯

Citations

Apr 25, 2012·Journal of Gastrointestinal Cancer·Hushan YangJinliang Xing
Jan 11, 2012·The Pharmacogenomics Journal·L ChenK M Giacomini
Apr 28, 2012·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Alexandru SzathmariMichelle Fèvre Montange
Jan 28, 2010·Pharmacological Reviews·Curtis D Klaassen, Lauren M Aleksunes
Jan 5, 2011·Biological Chemistry·Shivangi GuptaYohannes Hagos
May 28, 2010·Pharmacogenomics·Ekaitz Errasti-Murugarren, Marçal Pastor-Anglada
Oct 1, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sarah SpreckelmeyerAngela Casini
Jul 17, 2009·Expert Opinion on Investigational Drugs·Teni Boulikas
Oct 1, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Francesco CreaEnrico Mini
Jan 22, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Herman BurgerErik A C Wiemer
Dec 29, 2009·The Journal of Surgical Research·Liselot B J van IerselPeter J K Kuppen
Jul 11, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anne T NiesElke Schaeffeler
Jun 4, 2014·Biopharmaceutics & Drug Disposition·Nancy N Jong, Mark J McKeage
May 12, 2009·Biochemical Pharmacology·Naoko KimuraKen-ichi Inui
Sep 19, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Na HeLongli Kang
Jun 30, 2014·Neuro-Chirurgie·A SzathmariM Fèvre Montange
Jun 24, 2011·Journal of Cardiovascular Pharmacology·Thomas F SolbachOliver Zolk
Dec 19, 2018·International Journal of Cancer. Journal International Du Cancer·Anjing RenLingjun Zhu
May 16, 2019·Epigenetics : Official Journal of the DNA Methylation Society·Qianying ZhuSu Zeng
May 20, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Robert S FotiDan A Rock
Jan 7, 2020·Current Drug Metabolism·Kanisha Shah, Rakesh M Rawal
Jan 1, 2014·Molecular and Cellular Therapies·Qing Li, Yan Shu
Dec 20, 2019·Pharmacological Reviews·Hermann Koepsell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.